Results 251 to 260 of about 699,709 (340)

Role of tumor‐associated lymphatic endothelial cells in metastasis: A study of epithelial ovarian tumor in vitro

open access: green, 2009
Shouhua Yang   +7 more
openalex   +2 more sources

Epithelial‐mesenchymal transition in cancer metastasis through the lymphatic system [PDF]

open access: gold, 2017
Mikael C. I. Karlsson   +3 more
openalex   +1 more source

Neoadjuvant Chemotherapy With Cisplatin Up‐Regulates GSDMD to Enhance Oral Squamous Cell Carcinoma Metastasis Through MMP14‐Mediated EMT Activation

open access: yesAdvanced Science, EarlyView.
Oral squamous cell carcinoma cells exhibit upregulated expression of GSDMD upon exposure to low‐dose cisplatin chemotherapy, which subsequently interacts with MMP14 through its N‐terminal domain, activating the epithelial‒mesenchymal transition (EMT) process and promoting the lymph node metastasis of oral squamous cell carcinoma.
Zixian Huang   +9 more
wiley   +1 more source

An HGF-dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis. [PDF]

open access: yesCancer Commun (Lond), 2023
Li Y   +10 more
europepmc   +1 more source

Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma

open access: hybrid, 2009
Chun-Feng Lee   +6 more
openalex   +1 more source

The fibrinolysis inhibitor α2-antiplasmin restricts lymphatic remodelling and metastasis in a mouse model of cancer [PDF]

open access: hybrid, 2017
Sophie Paquet‐Fifield   +8 more
openalex   +1 more source

Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer

open access: yesAdvanced Science, EarlyView.
It is reported that Fn14 inhibited EOC metastasis by regulating Slug‐mediated EMT. Furthermore, Fn14 altered the subcellular localization of SIRT2 by interacting with SIRT2, leading to reduced SIRT2 shuttling into the nucleus and subsequently promoting the acetylated degradation of Slug.
Anyue Wu   +9 more
wiley   +1 more source

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2023
Volk A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy